Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress

Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress

Sussex Research Laboratories Inc., leading GalNAc and carbohydrate targeting ligand specialist, is excited to announce sponsorship of the 8th Annual OPT Congress - Oligonucleotide & Precision Therapeutics!

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development. Visit us at booth 16 from March 13-14, 2023 in Boston, Massachusetts, USA!

Back to blog

About Sussex Research Laboratories Inc.

Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists.

  • Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

  • Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

  • Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

1 of 3